Gitnux/Report 2026

Clinical Laboratory Industry Statistics

Explore how the clinical laboratory sector is performing and evolving, from LabCorp’s 2023 net revenues of USD 12.16 billion to the fast shift toward automation and AI, including 42% global AI adoption by 2023. The page brings together profitability, market size, test volumes, and technology trends to help you quickly spot where value and demand are heading next.
270Statistics
58Sources
12Sections
1Visuals
45mRead
November 11, 2026Updated
Clinical Laboratory Industry Statistics
Priya ChandrasekaranWritten by Priya Chandrasekaran·Edited by Daniel Varga·Fact-checked by Yumi Nakamura
Published ·Updated
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 31 days

01 Industry overview

The clinical laboratory industry at a glance

The global clinical laboratory services market was valued at $224.4 billion in 2025 and is expanding as chronic disease, preventive screening, molecular diagnostics, and automation increase testing demand.

$224.4B[47]
Global market size, 2025
4.3%[47]
Global forecast CAGR, 2026–2033
38.2%[47]
North America share, 2025
301,284[39]
Registered U.S. laboratories, 2026
Market size
The global clinical laboratory services market was valued at $224.4 billion in 2025. The U.S. market was valued at $73.9 billion in 2025, representing about one-third of the global total on the cited estimates.[47]
Forecast & CAGR
The global market is projected to reach $308.2 billion by 2033, implying a 4.3% CAGR from 2026 to 2033. The U.S. market is projected to reach $95.9 billion by 2033 at a 3.4% CAGR.[47]
Market share & regions
North America accounted for 38.2% of global clinical laboratory services revenue in 2025, the largest regional share. The United States was the largest individual country market in 2025.[47]
Segmentation
Clinical chemistry was the largest global test-type segment, with a 44.5% share in 2025, while hospital-based laboratories accounted for 56.9% of revenue. In the U.S., clinical chemistry held approximately 43.9% of the market and diagnostic laboratories represented 44.2% by end use in 2025.[47]
Key players & concentration
The U.S. market includes national reference laboratories such as Quest Diagnostics and Labcorp, regional and hospital laboratories, physician-office laboratories, and specialty providers including Natera, NeoGenomics, ARUP Laboratories, and Mayo Clinic Laboratories. CMS recorded 301,284 registered laboratories in September 2026, indicating that the market remains highly fragmented despite continuing consolidation.[47][39]
Trends, drivers & challenges
Growth is being supported by chronic disease prevalence, preventive screening, early diagnosis, molecular and genetic testing, and laboratory automation. Key challenges include intense competition, reimbursement pressure, compliance costs, staffing requirements, and the operational complexity of managing high testing volumes across decentralized sites.[47][48]
Consumer behavior & competition
Quest Diagnostics reports that it serves one-third of American adults each year and half of U.S. physicians and hospitals. Competition is occurring across routine testing, specialty and genomic diagnostics, hospital outreach, service access, technology, and turnaround time.[18][48]
M&A
M&A remains a major route to scale and specialty expansion. In October 2026, Labcorp agreed to acquire select BioReference Health assets, including clinical and women's health testing businesses and more than 80 patient service centers; in September 2026, Labcorp also acquired MLM Medical Labs to expand central-laboratory and biomarker capabilities.[14]
Regulation
U.S. laboratories are regulated primarily through CLIA, which covers approximately 320,000 laboratory entities and applies standards based on testing complexity. FDA's 2024 laboratory-developed-test rule was vacated by a federal district court on March 31, 2025, and FDA reverted the regulation to its prior text on September 19, 2025.[39][49]
Latest news
Recent industry activity has centered on consolidation and global specialty testing. Labcorp announced its October 2026 agreement to acquire select BioReference Health assets, while its August 2026 acquisition of MLM Medical Labs expanded operations across the United States, Germany, and South Africa.[14]

02 Ranking

Top 10 Companies in the Clinical Laboratory Industry

The leading companies in the clinical laboratory industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 11, 2026 · Next review December 11, 2026

Verdict

Roche leads Gitnux's 2026 clinical laboratory ranking with an Overall score of 9.2, with CHF 13.847 billion in 2025 sales in diagnostics and lab systems. Siemens Healthineers is the runner-up at 9.1, driven by about €23.4 billion fiscal 2025 revenue for lab diagnostics and point-of-care.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in in-vitro diagnostics

    Roche

    CH

    Ranked #1 · 9.2 · In-vitro diagnostics

    Why we picked it: It operates in IVD and lab systems, adding automated mass-spectrometry test offerings.

    See in ranking ↓Visit roche.com ↗

  2. Leader in clinical lab services

    Labcorp

    US

    Ranked #3 · 9.0 · Clinical lab services

    Why we picked it: Its scale in clinical laboratory and patient-access channels supports high testing throughput.

    See in ranking ↓Visit labcorp.com ↗

  3. Leader in genetic testing

    Natera

    US

    Ranked #4 · 9.0 · Genetic testing

    Why we picked it: Its genetic and cell-free DNA services concentrate on genomic test processing volumes.

    See in ranking ↓Visit natera.com ↗

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the clinical laboratory industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Roche

In-vitro diagnostics · CH

9.2
2

Siemens Healthineers

In-vitro diagnostics · DE

9.1
3

Labcorp

Clinical lab services · US

9.0
4

Natera

Genetic testing · US

9.0
5

Werfen

In-vitro diagnostics · ES

8.9
6

Quest Diagnostics

Reference, routine and specialty laboratory testing · US

8.7
7

Thermo Fisher Scientific

Clinical diagnostics instruments and laboratory reagents · US

8.5
8

QuidelOrtho

Immunohematology, molecular and point-of-care diagnostics · US

8.5
9

Danaher

Clinical instruments, consumables and diagnostic systems · US

8.3
10

Hologic

Women's health and molecular diagnostics · US

8.3

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 11, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Priya Chandrasekaran. (2026, February 13). Top 10 companies in the clinical laboratory industry. In Clinical Laboratory Industry Statistics. Gitnux. https://gitnux.org/clinical-laboratory-industry-statistics/#top-companies

report visual · Projection

Labor compensation in medical laboratories (NAICS 621511) (United States)

Labor compensation in medical laboratories (NAICS 621511) grew from $22.8B in 2021 to $24.0B in 2025.

$22.8B
Start
+1.33%
CAGR · 4y
$24B
Projected
20212025
source-verifiedfred.stlouisfed.org2025

04 Statistics

Technology & Innovation

Adoption patterns center on automation and data handling. In the U.S., 30% of medical laboratory professionals ensured system integration when adopting automation tools in 2026.

AI in the clinical laboratory industry

  • 18% of Albanian clinical laboratory professionals reported using AI for auto-verification of laboratory test results in 2026.[1]
  • 52% of Albanian clinical laboratory professionals identified hematology as a laboratory section that could benefit most from AI in 2026.[1]
  • 15% of Albanian clinical laboratory professionals reported using AI for digital image analysis in 2026.[1]
  • 46% of Albanian clinical laboratory professionals reported that AI elements were already in use in their laboratories in 2026.[1]
  • 43% of Albanian clinical laboratory professionals identified clinical chemistry as a laboratory section that could benefit most from AI in 2026.[1]
  • 31% of Albanian clinical laboratory professionals expressed concern about losing their jobs because of AI replacement in 2026.[1]

Automation in the clinical laboratory industry

  • 48% of U.S. medical laboratory professionals reported using a train-the-trainer model when introducing new laboratory software in 2026.[2]
  • 56.3% of U.S. medical laboratories reporting technology-driven staffing changes in 2024 identified automation as the technology causing the greatest change.[3]
  • 61% of U.S. medical laboratory professionals reported creating standard workflows for all laboratory employees when training staff on new software in 2026.[2]
  • 33% of U.S. medical laboratory professionals cited automated equipment as technology needed to cover staff shortages in 2026.[2]
  • 30% of U.S. medical laboratory professionals ensured system integration for seamless data flows when adopting automation tools in 2026.[2]
  • 39% of U.S. medical laboratory professionals involved their IT department early when adopting laboratory automation tools in 2026.[2]

Digital Transformation in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[4]
  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[5]
  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[6]
  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[7]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[6]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[5]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[8]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 72% used data from smart devices or sensors in 2024.[9]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 77% used in-house staff rather than external providers in 2024.[9]

05 Statistics

Data & Analytics

Data and analytics usage varies by tool integration and governance. In 2025, 36% of surveyed laboratories reported analytics tools integrated with their LIS.

Business intelligence in the clinical laboratory industry

  • 17% of surveyed laboratories used separate data-analytics tools in 2025.[2]
  • 20% of surveyed laboratory professionals used third-party business-intelligence platforms in 2025.[2]
  • 28% of surveyed laboratory professionals used custom-built internal dashboards in 2025.[2]
  • 33% of surveyed laboratory professionals used instrument-provided analytics for reporting and decision-making in 2025.[2]
  • 36% of surveyed laboratories used analytics tools integrated with their LIS in 2025.[2]
  • 27% of surveyed laboratories used analytics tools that were part of their LIS in 2025.[2]

Data analytics in the clinical laboratory industry

  • 11% of surveyed laboratory professionals were not yet using data analytics significantly but wanted to start in 2025.[2]
  • 53% of surveyed laboratory professionals identified cybersecurity and access control as data-security challenges in 2025.[2]
  • 27% of surveyed laboratories benchmarked internally across sites or departments in 2025.[2]
  • 65% of surveyed laboratory organizations had dedicated cybersecurity resources in 2025.[2]
  • 72% of surveyed laboratory organizations required vendor risk assessments in 2025.[2]
  • 48% of surveyed laboratory professionals identified staff training and data literacy as analytics challenges in 2025.[2]

Data Quality in the healthcare services sector (sector benchmark)

  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[10]
  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[11]
  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[11]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[11]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[11]

Data Governance in the healthcare services sector (sector benchmark)

  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[10]
  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[10]
  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[10]
  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[10]
  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[10]
  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[10]

KPIs in the clinical laboratory industry

  • 48% of surveyed laboratory professionals measured staff productivity goals as an operational KPI in 2025.[2]
  • 87% of surveyed laboratory professionals measured turnaround time as an operational KPI in 2025.[2]
  • 64% of surveyed laboratory professionals measured cost per test as an operational KPI in 2025, up from 54% in 2024.[2]
  • 57% of surveyed laboratory professionals measured cost per test as an operational KPI in 2025.[2]
  • 73% of surveyed laboratory professionals measured quality-improvement initiatives as an operational KPI in the 2025 MLO survey.[2]
  • 46% of surveyed laboratory professionals measured billable tests versus performed tests as an operational KPI in 2025.[2]

06 Statistics

Strategy & Growth

Scale and test menu breadth show up in multi-year offerings and acquisitions. Labcorp reported 6,500+ tests offered in 2025 alongside 750+ million tests worldwide.

Growth in the clinical laboratory industry

  • 6,500+ tests were offered by Labcorp in 2025 as part of its expansion of diagnostic capabilities.[12]
  • 750+ million tests represented Labcorp’s worldwide testing volume in 2025.[12]
  • 200,000+ analytical methods were available across Eurofins’ network in 2025.[13]
  • 450+ million tests per year were supported by Eurofins’ laboratory network in 2025.[13]
  • €343 million was spent by Eurofins on 31 business combinations closed in 2024.[13]
  • $722 million was the cash purchase price announced for Labcorp’s 2026 acquisition of select BioReference Health assets.[14]

Differentiation in the clinical laboratory industry

  • 200,000+ analytical methods differentiated Eurofins’ laboratory offering in 2025.[13]
  • 750+ million tests demonstrated Labcorp’s scale-based diagnostic-services offering in 2025.[12]
  • 6,500+ tests differentiated Labcorp’s clinical testing menu in 2025.[12]
  • 4Kscore was included among the specialized diagnostic assets Labcorp agreed to acquire from BioReference Health in 2026.[14]

Mergers and acquisitions in the clinical laboratory industry

  • €343 million was the acquisition cost for Eurofins’ 31 business combinations closed in 2024.[13]
  • $100 million was paid by Quest Diagnostics for select assets of PathAI Diagnostics in 2024.[15]
  • $722 million in cash was the purchase price announced for Labcorp’s 2026 acquisition of select BioReference Health assets.[14]
  • $150 million was the maximum additional earnout tied to Labcorp’s 2026 acquisition of BioReference Health’s 4Kscore Test.[14]
  • 31 business combinations were closed by Eurofins during 2024.[13]
  • $300 million was paid by Quest Diagnostics for the laboratory businesses of three New York physician groups in 2024.[15]

Strategic partnerships in the clinical laboratory industry

  • 31 laboratory sites were covered by the reported Americas footprint of the global laboratory network at the end of 2025.[16]
  • 21 Memorial Hermann hospital laboratories were covered by Quest Diagnostics’ multi-year professional laboratory-management agreement.[17]
  • 21 Corewell Health inpatient and outpatient hospital laboratories were included in Quest Diagnostics’ 2025 joint-venture agreement.[18]
  • $5 million was the maximum three-year value of Contra Costa County’s 2025 outside-laboratory-services contract with Quest Diagnostics.[19]

07 Statistics

People & Workforce

Workforce constraints remain operational. In 2026, 63% of U.S. laboratory professionals said personnel shortages had a moderate or large operational impact.

Hiring in the clinical laboratory industry

  • 41% of U.S. medical laboratory professionals worked in laboratories with 20 or fewer employees in 2026.[2]
  • 37% of U.S. medical laboratory professionals cited partnerships with local colleges and technical schools for internships as a recruitment strategy in 2026.[2]
  • 30% of U.S. medical laboratory professionals reported that hiring qualified staff was very difficult in 2025.[2]
  • 22% of U.S. medical laboratory professionals worked in laboratories employing more than 100 people in 2026.[2]
  • 13% of U.S. medical laboratory professionals reported no difficulty hiring qualified staff in 2025.[2]

Employee retention in the clinical laboratory industry

  • 57% of U.S. medical laboratory professionals reported moderate staff turnover in 2025.[2]
  • 13% of U.S. laboratory professionals had less than three years of tenure with their current organization in 2026.[2]
  • 63% of U.S. laboratory professionals said personnel shortages had a moderate or large operational impact in 2026.[2]
  • 16% of U.S. medical laboratory professionals reported high staff turnover in 2025.[2]
  • 31% of U.S. laboratory professionals believed they had adequate career-advancement opportunities in 2026.[2]

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[20]
  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[20]
  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[20]
  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[21]

Hybrid Work in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[20]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[20]
  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[20]
  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[20]
  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[21]

Upskilling in the clinical laboratory industry

  • 34% of U.S. medical laboratory professionals reported using vendor-hosted in-house or online training for new software in 2026.[2]
  • 32% of U.S. medical laboratory professionals reported using annual online education refreshers for new software in 2026.[2]
  • 20% of U.S. medical laboratory professionals were somewhat dissatisfied with their laboratory education and training programs in 2025.[2]
  • 46% of U.S. medical laboratory professionals cited continuing education as a recruitment or retention strategy in 2026.[2]
  • 9% of U.S. medical laboratory professionals were very dissatisfied with their laboratory education and training programs in 2025.[2]

Employee Engagement in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[22]
  • Across NHS staff, the national staff-engagement theme score was 6.64 in the second quarter of 2024/25.[23]
  • Across U.S. healthcare workers, 78% believed their organization cared about their safety in 2024.[22]
  • U.S. registered nurses with low teamwork scores were 1.53 times more likely to leave their healthcare organization in 2024.[22]
  • Across 2.3 million U.S. healthcare workers, employee engagement declined by 0.02 points in 2024.[22]

DEI in the clinical laboratory industry

  • 46% of U.S. medical laboratory professionals responding to the 2025 survey held bachelor’s degrees.[2]

08 Statistics

Customer & Sales

Experience measures concentrate on ordering, collection, and turnaround time. In the United States, 84% of members were satisfied with turnaround time for laboratory results.

Customer experience in the clinical laboratory industry

  • 85% of members were satisfied with customer service at their lab provider in the United States.[17]
  • 3.9 was the median overall nursing-satisfaction score for clinical laboratory services across 162 U.S. hospital laboratories, on a 1-to-5 scale.[24]
  • 87% of members were satisfied with their overall recent lab-test experience in the United States.[17]
  • 88% of members were satisfied with the ease of the sample-collection process in the United States.[17]
  • 84% of members were satisfied with the turnaround time for laboratory results in the United States.[17]

Customer retention in the clinical laboratory industry

  • 28% of members identified a lack of trust in some aspect of the laboratory experience as a top reason to discontinue using a lab provider.[17]
  • 98% was Ortho Clinical Diagnostics’ approximate revenue-retention rate in 2020.[15]
  • 33% of members said they would continue using a laboratory when its location was convenient.[17]
  • 26% of members identified poor customer service as a top reason to discontinue using a laboratory provider.[17]
  • More than 30% was the reduction in Ortho Clinical Diagnostics’ service-intervention rate since mid-2014, supporting customer retention.[15]

Customer loyalty in the clinical laboratory industry

  • More than 15 years was Beckman Coulter’s reported average customer relationship in clinical diagnostics.[25]
  • 90% or more of Ortho Clinical Diagnostics’ revenue was recurring, supporting long-term laboratory customer relationships.[15]
  • Almost 15 years was the average Transfusion Medicine customer relationship reported by Ortho Clinical Diagnostics.[15]
  • Almost 13 years was the average Clinical Laboratories customer relationship reported by Ortho Clinical Diagnostics.[15]

Lead generation in the clinical laboratory industry

  • 16% of The Dark Intelligence Group’s clinical-laboratory and pathology audience were chief information officers in 2023.[26]
  • 28% of The Dark Intelligence Group’s clinical-laboratory and pathology audience worked in marketing or sales in 2023.[26]
  • 31% of The Dark Intelligence Group’s clinical-laboratory and pathology audience were laboratory or medical directors in 2023.[26]
  • 45% of The Dark Intelligence Group’s clinical-laboratory and pathology audience came from independent laboratories in 2023.[26]
  • 29% of The Dark Intelligence Group’s clinical-laboratory and pathology audience came from pathology laboratories in 2023.[26]

09 Statistics

Marketing & Brand

Audience targeting relies on professional roles and social platforms. In 2023, 83.4% of surveyed U.S. medical laboratory-science professionals with social-media accounts used Facebook.

Marketing in the clinical laboratory industry

  • 45% of The Dark Intelligence Group’s target organizations were independent laboratories in 2023.[26]
  • 14% of The Dark Intelligence Group’s target clinical-laboratory and pathology audience were CEOs, COOs or CFOs in 2023.[26]
  • 28% of The Dark Intelligence Group’s target clinical-laboratory and pathology audience were marketing or sales professionals in 2023.[26]
  • 31% of The Dark Intelligence Group’s target clinical-laboratory and pathology audience were laboratory or medical directors in 2023.[26]
  • 1,000 or more executives, senior administrators, pathologists and consultants attended The Dark Report’s annual laboratory-management conference in 2023.[26]

Social media in the clinical laboratory industry

  • 83.4% of surveyed U.S. medical laboratory-science professionals with social-media accounts used Facebook in 2023.[24]
  • 50.2% of surveyed U.S. medical laboratory-science professionals with social-media accounts cited socializing as a use in 2023.[24]
  • 60.8% of surveyed U.S. medical laboratory-science professionals with social-media accounts used Instagram in 2023.[24]
  • 60.8% of surveyed U.S. medical laboratory-science professionals with social-media accounts cited entertainment as a use in 2023.[24]
  • 50.7% of surveyed U.S. medical laboratory-science professionals with social-media accounts used LinkedIn in 2023.[24]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 33% of U.S.-focused health and wellness influencers promoted a product, service or subscription in more than half of their posts in 2026.[27]
  • 50% of healthcare and pharmaceutical marketers reported dedicated, growing creator/influencer budgets in 2026, compared with 58% globally.[28]
  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[29]
  • 50% of U.S. physicians surveyed had changed prescribing choices based on healthcare influencer or KOL content on social media in 2024.[30]
  • 38% of posts from U.S.-focused health and wellness influencers promoted a product, service or subscription in 2026.[27]

10 Statistics

Operations & Execution

Operational measurement and LIS integration drive execution. In 2025, 89% of U.S. laboratory professionals reported measuring turnaround time as an operational KPI.

Process optimization in the clinical laboratory industry

  • 89% of U.S. laboratory professionals reported measuring turnaround time as an operational KPI in 2025.[2]
  • 63% of U.S. laboratory professionals said technology investments primarily target efficiency improvement or cost reduction in 2026.[2]
  • 31% of laboratories with analytics tools used a separate analytics tool rather than LIS-integrated analytics in 2023.[31]
  • 40% of laboratories reported adopting analyzers that enable walkaway testing in 2026.[2]
  • 69% of laboratories with analytics tools reported integrating them with the LIS in 2023.[31]

Operational efficiency in the clinical laboratory industry

  • 39% of U.S. laboratory professionals reported measuring staff-productivity goals as a KPI in 2024.[2]
  • 54% of U.S. laboratory professionals reported measuring cost per test as an operational KPI in 2024.[2]
  • 37% of U.S. laboratory professionals reported measuring medical necessity as a KPI in 2024.[2]
  • 48.3% was the reduction in hospital-wide specimen-collection time reported after a laboratory digital-transformation initiative in Taiwan.[32]
  • 70% of U.S. laboratories reported using in-house software or servers in 2024.[2]

Quality management in the clinical laboratory industry

  • 0.8% of U.S. Certificate of Accreditation laboratories surveyed by CMS had a deficiency specifically related to specimen identification and integrity in 2018.[33]
  • 62.18% of nonconformities in an Indian clinical biochemistry laboratory were attributed to human error during March 2023–February 2024.[34]
  • 51% of U.S. laboratories reported measuring cost per test as an operational performance indicator in 2023.[31]
  • 35% of U.S. laboratories reported measuring billable tests versus performed tests as an operational performance indicator in 2023.[31]
  • 71% of U.S. laboratory professionals reported measuring quality-improvement initiatives as an operational KPI in 2024.[2]

Supply chain in the clinical laboratory industry

  • 16% of medical laboratory professionals reported difficulty sourcing laboratory plastics in 2024.[2]
  • 21% of medical laboratory professionals reported difficulty sourcing culture media in 2024.[2]
  • 36% of medical laboratory professionals reported no difficulty sourcing the listed testing supplies in 2024.[2]
  • 10% of medical laboratory professionals reported difficulty sourcing swabs or other consumables in 2024.[2]
  • 11% of medical laboratory professionals reported difficulty sourcing pipettes in 2024.[2]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[35]
  • 18% of U.S. medical-group leaders planned to outsource or automate patient communications in contact centers in 2024, according to an MGMA poll with 262 responses.[20]
  • 54% of global healthcare providers used third-party providers for supply-chain services in 2024, based on a survey of 28 healthcare-provider executives.[35]
  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[35]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[35]

11 Statistics

Finance & Pricing

Cost reduction in the clinical laboratory industry

  • 66% of U.S. laboratory professionals ranked funding as a high short-term planning and forecasting challenge in 2025.[2]
  • 47% of U.S. laboratory professionals reported measuring staff-productivity goals in 2025.[2]
  • 54% of U.S. laboratories reported measuring cost per test in 2024.[2]
  • 64% of U.S. laboratory professionals reported measuring cost per test in 2025.[2]
  • 18% of laboratories reported securing electronic inventory tracking from supply-chain or materials-management departments in 2025.[2]

Profitability in the clinical laboratory industry

  • 54% of Quest Diagnostics’ 2025 net revenue came from routine clinical testing and other services.[36]
  • 13.6% was Quest Diagnostics’ operating margin in 2024.[15]
  • $11.0 billion was Quest Diagnostics’ total net revenue in 2025.[36]
  • 0.1% was Quest Diagnostics’ revenue-per-requisition change in 2025.[15]
  • 244 million test requisitions were processed by Quest Diagnostics during 2025.[15]

Financial planning in the clinical laboratory industry

  • 33% of U.S. laboratory professionals cited lack of interoperability between LIS and revenue-cycle platforms as a reimbursement-tracking barrier in 2026.[2]
  • 45% of U.S. laboratory professionals reported being able to track whether reimbursement covered testing costs in 2024.[2]
  • 32% of U.S. laboratory professionals reported being able to track whether reimbursement fully covers testing costs in 2026.[2]
  • 33% of U.S. laboratory professionals reported being able to track whether reimbursement covered testing costs in 2025.[2]

12 Statistics

Product & Service

Product launches and delivery interfaces support throughput. Roche’s automated mass-spectrometry platform offered 39 in-vitro diagnostic tests after its 2025 expansion.

Product development in the clinical laboratory industry

  • 2 new instrument platforms were introduced by Roche Diagnostics globally in 2025.[37]
  • 3 new core-laboratory platforms and 10 new core-laboratory tests were launched by Roche in 2024.[37]
  • 1 new near-patient-care platform and 3 new near-patient-care tests were launched by Roche in 2024.[37]
  • 5 new information-solution products were launched by Roche in 2024.[37]
  • 6 new pathology-laboratory tests were launched by Roche in 2024.[37]

Product lifecycle in the clinical laboratory industry

  • Roche’s automated mass-spectrometry platform offered 39 in-vitro diagnostic tests after its 2025 expansion.[37]
  • 30 billion diagnostic tests were delivered to Roche customers worldwide in 2024.[37]
  • Quest Diagnostics generated $9.9 billion in net revenue in 2024.[15]
  • Quest Diagnostics served approximately one-half of U.S. adults over a three-year period in 2024.[15]
  • Roche’s Elecsys Dengue Ag test delivered results in 18 minutes after its 2025 launch.[37]

Value proposition in the clinical laboratory industry

  • 6,800-plus in-office phlebotomists supported Labcorp customer offices and facilities in 2024.[15]
  • 10% of Labcorp Diagnostics revenue came directly from patients in North America in 2024.[15]
  • 80,000-plus electronic interfaces supported Labcorp diagnostic-result delivery in 2024.[15]
  • 36% of Labcorp Diagnostics revenue came from third-party payers in North America in 2024.[15]
  • 24% of Labcorp Diagnostics revenue came from clients in North America in 2024.[15]

13 Statistics

Sustainability & Ethics

Waste and emissions metrics track operational footprint. In U.S. academic laboratories, 995 kg of solid waste was generated per 1 million basic metabolic panels on Abbott wet-chemistry analyzers in 2022.

Sustainability in the clinical laboratory industry

  • More than 50% of solid waste from 100,000 basic metabolic panels was attributed to phlebotomy supplies in a U.S. clinical-laboratory study.[3]
  • 489 kg of solid waste was generated per 1 million basic metabolic panels on Siemens analyzers in U.S. academic laboratories in 2022.[24]
  • 995 kg of solid waste was generated per 1 million basic metabolic panels on Abbott wet-chemistry analyzers in U.S. academic laboratories in 2022.[24]
  • 160,593 kg of solid waste was generated per 1 million basic metabolic panels on Ortho dry-chemistry systems in U.S. academic laboratories in 2022.[24]
  • Liquid waste varied 32-fold, from 10.8 liters to 346.6 liters, across four analyzers processing 100,000 basic metabolic panels.[3]

ESG in the clinical laboratory industry

  • Labcorp received an A CDP Supplier Engagement Assessment score for managing climate risks across its supply chain in 2025.[12]
  • Labcorp received an A− CDP Climate Change score for disclosure and climate-performance transparency in 2025.[12]
  • Labcorp received a Silver EcoVadis medal in 2025, placing it in the top 15% of companies evaluated for sustainability performance.[12]
  • Labcorp committed to reduce absolute Scope 3 greenhouse-gas emissions 25% by 2030 from its target baseline.[12]
  • Labcorp committed to reduce absolute Scope 1 and 2 greenhouse-gas emissions 42% by 2030 from its target baseline.[12]

Ethics in the clinical laboratory industry

  • 48.2% of reported clinical-laboratory diagnostic errors involved incorrect test ordering in a Thai private hospital network.[3]
  • 89.2% of reported clinical-laboratory diagnostic errors occurred in the pre-analytical process in a Thai private hospital network.[3]
  • 91.1% of reported clinical-laboratory diagnostic errors were attributed to human factors in a Thai private hospital network.[3]
  • 2.9% was the diagnostic-error rate across three years of voluntary clinical-laboratory incident reports in a large private hospital network in Thailand.[3]

CSR in the clinical laboratory industry

  • Quest Diagnostics reduced gasoline consumption by approximately 79,900 gallons through courier-route optimization in 2024.[38]
  • Quest Diagnostics operated 39 active programs improving diagnostic-service access and community-care resources in 2024.[38]
  • Quest Diagnostics reduced courier fleet travel by approximately 2.228 million miles through route optimization in 2024.[38]

Circular economy in the clinical laboratory industry

  • 233.6 kg of reagent-kit waste was recyclable from annual comprehensive metabolic-panel testing at a U.S. tertiary-care laboratory in 2021–2022.[3]
  • 21.4% of reagent-kit waste from a U.S. clinical laboratory’s annual comprehensive metabolic panels was recyclable in 2021–2022.[3]
  • Quest Diagnostics’ waste-to-energy conversion generated approximately 1,070,850 kWh of electricity in 2024.[17]
  • 855.5 kg of reagent-kit waste was nonrecyclable from annual comprehensive metabolic-panel testing at a U.S. tertiary-care laboratory in 2021–2022.[3]
  • Approximately 3,900 tons of waste were diverted from landfill by Quest Diagnostics through recycling and waste-to-energy programs in 2024.[17]

Carbon footprint in the clinical laboratory industry

  • Quest Diagnostics reported 375,085 metric tons of Scope 3 emissions from purchased goods and services across its full portfolio in 2025.[17]
  • Quest Diagnostics avoided approximately 10,000 metric tons of CO2e through waste-to-energy conversion and recycling in 2024.[38]
  • Quest Diagnostics avoided approximately 700 metric tons of CO2 emissions through courier-route optimization in 2024.[38]
  • 69,665 kg CO2e of annual emissions were associated with electricity and water use for 1 million basic metabolic panels across five U.S. analyzer systems.[24]
  • Quest Diagnostics eliminated approximately 219 tons of CO2e emissions through laboratory sustainability initiatives in 2024.[17]

15 Statistics

Globalization & Expansion

Cross-border lab networks support volume and coverage. Labcorp’s clinical laboratory business served ~100 countries in 2025.

Globalization in the clinical laboratory industry

  • 87 laboratory sites operated across 27 countries at the end of 2025 for the reported global laboratory network.[16]
  • 65,000+ employees supported Eurofins’ laboratory network across 59 countries in 2025.[13]
  • ~100 countries were served by Labcorp’s clinical laboratory business in 2025.[12]
  • 36 laboratory sites were located in Asia, 31 in the Americas and 20 in Europe, the Middle East and Africa at the end of 2025.[16]
  • ~71,000 employees worked for Labcorp across its global operations in 2025.[12]

Supplier management in the clinical laboratory industry

  • 140,000+ pieces of test equipment were used across the reported global laboratory network at the end of 2025.[16]
  • 5 million+ square feet was occupied by the 87-site laboratory network at the end of 2025.[16]
  • 3,400 employees worked in the reported 87-site laboratory network at the end of 2025.[16]
  • 21 inpatient and outpatient hospital laboratories were covered by Quest Diagnostics’ 2025 Corewell Health collaboration, including workforce and supply-chain management.[18]

Stakeholder management in the clinical laboratory industry

  • More than 85% of new drugs and therapeutic products approved by the FDA in 2025 received support from Labcorp.[14]
  • 6,500+ tests were offered by Labcorp during 2025.[12]
  • More than 75% of new drugs and therapeutic products approved by the FDA in 2024 received support from Labcorp.[12]
  • 175 million patient interactions were recorded by Labcorp during 2025.[12]

Distribution channels in the clinical laboratory industry

  • 750+ million tests were delivered through Labcorp’s patient service, laboratory and digital-access channels in 2025.[12]
  • ~100 countries were reached through Labcorp’s global laboratory-services network in 2025.[12]
  • 175 million patient interactions were handled through Labcorp’s clinical laboratory and patient-access channels in 2025.[12]
  • $5 million was the maximum three-year contract value approved for outside clinical laboratory services from Quest Diagnostics for Contra Costa County health facilities.[19]
  • 21 hospital laboratories were included in Quest Diagnostics’ 2025 Memorial Hermann outreach-management model.[17]

Key questions about the Clinical Laboratory Industry

What is the market size for clinical laboratory services in 2025?
The global clinical laboratory services market was valued at $224.4 billion in 2025.
How fast is the clinical laboratory services market expected to grow after 2025?
The global market is projected to reach $308.2 billion by 2033, implying a 4.3% CAGR from 2026 to 2033.
Which companies lead the clinical laboratory industry?
Roche leads Gitnux's 2026 clinical laboratory ranking with an Overall score of 9.2, with CHF 13.847 billion in 2025 sales in diagnostics and lab systems. Siemens Healthineers is the runner-up at 9.1, driven by about €23.4 billion fiscal 2025 revenue for lab diagnostics and point-of-care.
What technology shifts show up in 2026 for clinical laboratories?
Across U.S. medical laboratory professionals, 61% reported creating standard workflows when training staff on new software in 2026.
How fragmented is the U.S. clinical laboratory market structure in 2026?
CMS recorded 301,284 registered laboratories in September 2026, indicating high fragmentation despite consolidation.
How are reimbursement tracking and interoperability barriers described for 2026?
In 2026, 33% of U.S. laboratory professionals cited lack of interoperability between LIS and revenue-cycle platforms as a reimbursement-tracking barrier.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Priya Chandrasekaran. (2026, February 13). Clinical Laboratory Industry Statistics. Gitnux. https://gitnux.org/clinical-laboratory-industry-statistics
MLA
Priya Chandrasekaran. "Clinical Laboratory Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/clinical-laboratory-industry-statistics.
Chicago
Priya Chandrasekaran. 2026. "Clinical Laboratory Industry Statistics." Gitnux. https://gitnux.org/clinical-laboratory-industry-statistics.

Sources & references

58 sources cited across this report

  1. ifccfiles.com
  2. mlo-online.com
  3. academic.oup.com
  4. business.adobe.com
  5. healthit.gov
  6. deloitte.com
  7. kpmg.com
  8. go.rackspace.com
  9. cetic.br
  10. intersystems.com
  11. carta.healthcare
  12. labcorp.com
  13. cdnmedia.eurofins.com
  14. labcorp.gcs-web.com
  15. sec.gov
  16. d18rn0p25nwr6d.cloudfront.net
  17. questdiagnostics.com
  18. newsroom.questdiagnostics.com
  19. contra-costa.legistar.com
  20. mgma.com
  21. wfhresearch.com
  22. pressganey.com
  23. england.nhs.uk
  24. pubmed.ncbi.nlm.nih.gov
  25. annualreports.com
  26. darkdaily.com
  27. pewresearch.org
  28. brand-news.it
  29. media.sproutsocial.com
  30. sermo.com
  31. img.mlo-online.com
  32. intl.snq.org.tw
  33. gao.gov
  34. jcdr.net
  35. tcs.com
  36. s2.q4cdn.com
  37. roche.com
  38. financialfilings.com
  39. cms.gov
  40. ache.org
  41. proofpoint.com
  42. ponemonsullivanreport.com
  43. kff.org
  44. hfmmagazine.com
  45. sophos.com
  46. ir.questdiagnostics.com
  47. grandviewresearch.com
  48. ir.labcorp.com
  49. fda.gov
  50. siemens-healthineers.com
  51. investor.natera.com
  52. werfen.com
  53. stratec.com
  54. quidelortho.com
  55. publicnow.com
  56. cdc.gov
  57. bls.gov
  58. ascp.org